Skip to content
← Childhood Pheochromocytoma and Paraganglioma

FOR PATIENTS · SOURCE READING

Key Points

Source: Childhood Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: July 21, 2022 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview

There are different types of treatment for children with pheochromocytoma or paraganglioma.

Children with pheochromocytoma or paraganglioma should have their treatment planned by a team of doctors who are experts in treating childhood cancer.

Four types of standard treatment are used:

Four types of standard treatment are used:

Surgery

Four types of standard treatment are used:

Chemotherapy

Four types of standard treatment are used:

High-dose 131I-MIBG therapy

Four types of standard treatment are used:

Targeted therapy

New types of treatment are being tested in clinical trials.

Treatment of pheochromocytoma and paraganglioma may cause side effects.

Patients may want to think about taking part in a clinical trial.

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Follow-up tests may be needed.

Preserved source evidence · Independent clinical review pending · Not medical advice